Skip to main content

Table 2 The biomarker serum phospholipid fatty acids in wt% and quartiles (P25‚ 75), n = 49

From: Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment

Fatty acid, wt%

Time 0

Time 6

Time 12

Median

P25, 75

Median

P25, 75

Median

P25, 75

Sum n-3†

10.24

8.03–11.54

9.33

8.07–11.12

9.31

7.99–10.85

EPA

2.54

1.84–3.17

2.23

1.56–2.79

2.19

1.53–3.03

DHA

6.24

5.44–7.13

6.10

5.13–6.73

5.84

4.97–6.72

  1. wt%: Weight percent
  2. time 0: 2–8 days presurgery, time 6: 6 months postsurgery, time 12: 12 months postsurgery
  3. †Sum n-3: ALA (18:3n-3), EPA (20:5n-3), DPA (22:5n-3), DHA (22:6n-3)
Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us